Market header image

Bulletins

You are here

2017-0204 - Suspension - Abattis Bioceuticals Corp. (ATT)

February 6, 2017

Abattis Bioceuticals Corp. is in default of CSE requirements. Effective immediately, Abattis Bioceuticals will be suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt as defined in National Instrument 23-101 Trading Rules.  A cease trade order has been issued by the British Columbia Securities Commission and the Ontario Securities Commission.

Date: Effective immediately, February 6, 2017

Symbol: ATT

If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com

Advertisement

Publicité

Latest CSE News

Upcoming Events

01_19_Vancouver_Resource_Investment_Conference_Website

Vancouver Resource Investment Conference (VRIC)

Sunday, January 19, 2020 - 8:00am to Monday, January 20, 2020 - 6:00pm
01_20_CannaTech_Davos_2020_Website

CannaTech Davos 2020

Monday, January 20, 2020 (All day) to Friday, January 24, 2020 (All day)

Advertisement

Publicité